A Study of ABT-414 in Subjects With Solid Tumors
NCT01741727
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Squamous Cell Tumors
Interventions
DRUG:
ABT-414
Sponsor
AbbVie (prior sponsor, Abbott)